Displaying drugs 76 - 100 of 1616 in total
HSD-016
Hsd 016 is under investigation in clinical trial NCT00838461 (Study Evaluating the Safety, Pharmacokinetics (PK), and Pharmacodynamices (PD) of HSD-016).
Investigational
Matched Name: … HSD-016 …
Matched Description: … (PK), and Pharmacodynamices (PD) of HSD-016). ... Hsd 016 is under investigation in clinical trial NCT00838461 (Study Evaluating the Safety, Pharmacokinetics …
Matched Description: … (PK), and Pharmacodynamices (PD) of HSD-016). ... Hsd 016 is under investigation in clinical trial NCT00838461 (Study Evaluating the Safety, Pharmacokinetics …
AVI-014
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Investigational
Matched Name: … AVI-014 …
Matched Description: … AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF). …
Matched Description: … AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF). …
BCL-005
BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells.
Investigational
Matched Synonyms: … BCL-005 (fused (hybrid) melanoma-dendritic cells) …
Matched Name: … BCL-005 …
Matched Description: … BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells. …
Matched Name: … BCL-005 …
Matched Description: … BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells. …
MT-0169
MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein.
Investigational
Matched Name: … MT-0169 …
Matched Description: … MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to …
Matched Description: … MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to …
GPI-0100
GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the immune response.
The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety of vaccines, has been shown to have good overall performance characteristics on safety and efficacy.
Investigational
Matched Name: … GPI-0100 …
Matched Description: … GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the ... The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety …
Matched Description: … GPI-0100 is Avantogen’s lead adjuvanat-immunopotentiator, a key component of vaccines for boosting the ... The GPI-0100 adjuvant, which has been shown to significantly enhance the immune response with a variety …
GDC-0349
GDC-0349 has been used in trials studying the treatment of Non-Hodgkin's Lymphoma, Solid Tumor.
Investigational
Matched Name: … GDC-0349 …
Matched Description: … GDC-0349 has been used in trials studying the treatment of Non-Hodgkin's Lymphoma, Solid Tumor. …
Matched Description: … GDC-0349 has been used in trials studying the treatment of Non-Hodgkin's Lymphoma, Solid Tumor. …
GDC-0425
GDC-0425 is under investigation in clinical trial NCT01359696 (A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma).
Investigational
Matched Name: … GDC-0425 …
Matched Description: … GDC-0425 is under investigation in clinical trial NCT01359696 (A Study Evaluating the Safety, Tolerability ... , and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory …
Matched Description: … GDC-0425 is under investigation in clinical trial NCT01359696 (A Study Evaluating the Safety, Tolerability ... , and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory …
NGGT-002
NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase (PAH).
Investigational
Matched Name: … NGGT-002 …
Matched Description: … NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase …
Matched Description: … NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase …
AMGN-0007
Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.
Investigational
Matched Name: … AMGN-0007 …
Matched Description: … Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic …
Matched Description: … Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic …
GLPG-0187
GLPG0187 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Name: … GLPG-0187 …
GLPG-0492
Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
Investigational
Matched Name: … GLPG-0492 …
IMCY-0141
IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin sheath protecting the nerves.
Investigational
Matched Name: … IMCY-0141 …
Matched Description: … IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen …
Matched Description: … IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen …
PF-04991532
PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Glucose Metabolism Disorders.
Investigational
Matched Name: … PF-04991532 …
Matched Description: … PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes …
Matched Description: … PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes …
PF-03463275
PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments Associated With Schizophrenia.
Investigational
Matched Name: … PF-03463275 …
Matched Description: … PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments …
Matched Description: … PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments …
PF-04457845
PF-04457845 is under investigation in Fear Conditioning. PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
Investigational
Matched Name: … PF-04457845 …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
Displaying drugs 76 - 100 of 1616 in total